Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Phase I/II Study of Radiofrequency Ablation in Patients With Bone Metastases

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
Phase II, Phase I	Supportive care, Treatment	Closed	21 and over	NCI	ACRIN-6661 NCT00026247

Trial Description

Purpose:

Radiofrequency ablation may be effective in decreasing pain from bone metastases.

Phase I/II trial to study the effectiveness of radiofrequency ablation in decreasing pain in patients who have bone metastases.

Eligibility:

Eligibility criteria include the following:

• At least 21 years old
• Must have persistent uncontrollable pain from at least one site of bone metastases
• No lymphoma, leukemia, or primary muscle or bone cancer
• At least 2 weeks since since chemotherapy
• At least 1 month since radiation therapy
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will undergo radiofrequency ablation directly to the metastatic bone lesion. The degree of pain and mood will be evaluated periodically. Patients will be evaluated at 1 week, 1 month, and 3 months.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

American College of Radiology Imaging Network

Damian Dupuy, MD, Protocol chair		Ph: 401-444-5184

Registry Information
Official Title		A Phase I/II Study of Percutaneous Radiofrequency Ablation of Bone Metastases using CT Guidance
Trial Start Date		2001-11-01
Registered in ClinicalTrials.gov		NCT00026247
Date Submitted to PDQ		2001-09-07
Information Last Verified		2006-03-31
NCI Grant/Contract Number		CA080098

Back to Top